Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 24)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: BIOMIMETIC THERA -- BMTI1$4  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: BMTI , DYAI , OSIR , SNSS -- DRUGS3$4  View Abstract
5-Feb-10Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of BIOMIMETIC THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20  View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for BMTI: the economy's impact on BMTI's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: BIOMIMETIC THERAPEUTICS INC5$25  View Abstract
30-Jan-10Wright ReportsN/AWright Investors Service Comprehensive Report for Biomimetic Therapeutics, Inc.40$65  View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: BIOMIMETIC THERAPEUTICS INC5$25  View Abstract
20-Jan-10Zacks Investment Research Inc.N/ABIOMIMETIC THER (BMTI) Zacks Company Snapshot1$10  View Abstract
19-Jan-10Argus Research CorporationDavid ColemanVickers Weekly Insider, 01/19/201034$50  View Abstract
17-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: BIOMIMETIC THERAPEUTICS INC5$25  View Abstract
Next 14

Independent Reports (Showing 1 to 10 of 24)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: BIOMIMETIC THERA -- BMTI1$4View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: BMTI , DYAI , OSIR , SNSS -- DRUGS3$4View Abstract
5-Feb-10Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of BIOMIMETIC THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for BMTI: the economy's impact on BMTI's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: BIOMIMETIC THERAPEUTICS INC5$25View Abstract
30-Jan-10Wright ReportsN/AWright Investors Service Comprehensive Report for Biomimetic Therapeutics, Inc.40$65View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: BIOMIMETIC THERAPEUTICS INC5$25View Abstract
20-Jan-10Zacks Investment Research Inc.N/ABIOMIMETIC THER (BMTI) Zacks Company Snapshot1$10View Abstract
19-Jan-10Argus Research CorporationDavid ColemanVickers Weekly Insider, 01/19/201034$50View Abstract
17-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: BIOMIMETIC THERAPEUTICS INC5$25View Abstract
Next 14

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.